AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.63−0.57 (-3.52%)
Close on Nov 13, 2026Market cap $483.39MP/E –Yield –
AVITA Medical gross margin
Gross margin is gross profit as a percentage of revenue.
AVITA Medical's gross margin for the twelve months ending Sep 30, 2026 was 82.4%. For fiscal 2025 it was 82.1%, against 85.8% the year before. The highest annual figure on record is 85.8% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 82.1% | −3.7 |
| FY2024 | Dec 31, 2024 | 85.8% | +1.4 |
| FY2023 | Dec 31, 2023 | 84.5% | +4.8 |
| FY2021 | Jun 30, 2021 | 79.6% | +0.5 |
| FY2020 | Jun 30, 2020 | 79.2% | +2.4 |
| FY2019 | Jun 30, 2019 | 76.8% | +35.6 |
| FY2018 | Jun 30, 2018 | 41.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | 84.0% | +2.7 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 81.9% | +0.7 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 81.7% | −3.0 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 81.2% | −6.4 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 81.3% | −2.4 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 81.2% | −4.9 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 84.7% | −1.7 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 87.6% | +0.3 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 83.7% | −0.8 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 86.1% | +4.9 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 86.4% | +2.2 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 87.3% | +7.3 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 84.5% | +9.0 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 81.2% | −2.7 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 84.2% | +2.6 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 80.1% | +2.6 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | 75.5% | −8.1 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 83.9% | +9.9 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | 81.6% | +0.7 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | 77.5% | −2.0 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | 83.6% | +0.7 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 74.0% | −2.7 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | 81.0% | +67.2 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | 79.4% | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 82.9% | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 76.7% | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 13.8% | – |
See a number that looks wrong?